Table 2 Characteristics of patients with a positive Pneumocystis jirovecii qPCR
Patient, age, sex | Underlying disease | Date of PCP diagnosis | Viral association | Respiratory sample | Direct examination (IFI or MGG) | Pneumocystis qPCR | BDG (pg/ml)* | Time between ICU admission and positive sample (day) | Treatment |
|---|---|---|---|---|---|---|---|---|---|
P1, 58y, M | Diabetus mellitus Congestive heart failure | 14/01/2014 | Coronavirus, Rhinovirus | BAL | Negative | 36.7 | NA | 1 | No |
P2, 73y, M | Renal transplantation Diabetus mellitus Congestive heart failure | 29/08/2015 | Coronavirus | BAL | Positive | 32 | 106 | 0 | Yes (sulfamethoxazole) |
P3, 52y, M | Myasthenia (steroid, azathioprine) | 04/07/2012 | Respiratory syncytial virus | BAL | Negative | 39.8 | NA | 1 | No |
P4, 32y, F | Acute lymphoblastic leukemia (methotrexate and aracytabine) | 08/01/2019 | Metapneumovirus | BAL | Positive | 27.9 | 188 | 0 | Yes (sulfamethoxazole) |
P5, 67y, M | Cirrhosis, rheumatoid polyarthritis (steroid) | 22/04/2019 | Coronavirus NL63 | BAL | Negative | 36.6 | NA | 1 | No |